Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK CHF

Alcon Inc. (ALCZ.XC)

Compare
71.24
-1.24
(-1.71%)
As of 9:59:49 AM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
NameTitlePayExercisedYear Born
Mr. David J. Endicott CEO & Director 4.26M -- 1965
Mr. Timothy C. Stonesifer Senior VP & CFO -- -- 1967
Mr. Ian Bell Senior VP & COO -- -- 1971
Margaret Buckley Chief Accounting Officer -- -- --
Dr. Franck Leveiller SVP of Global Research & Development and Chief Scientific Officer -- -- --
Mr. Muru Murugappan Senior VP and Chief Information & Transformation Officer -- -- --
Mr. Royce R. Bedward J.D. Senior VP, General Counsel & Corporate Secretary -- -- 1966
Ms. Kimberly Martin Senior VP, Chief HR Officer & Corporate Communications -- -- 1975
Mr. Leon Sergio Duplan Fraustro Senior VP & President of Americas -- -- 1968
Mr. Laurent Attias SVP of Corporate Strategy, Business Development and Licensing (BD&L), M&A -- -- 1968

Alcon Inc.

Chemin de Blandonnet 8
Vernier
Geneva, 1214
Switzerland
41 589 112 110 https://www.alcon.com
Sector: 
Healthcare
Full Time Employees: 
25,599

Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Corporate Governance

Alcon Inc.’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 1; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events